摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 | 3051-84-1

中文名称
[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯
中文别名
——
英文名称
phosphoric acid adenosin-3'-yl ester uridin-5'-yl ester
英文别名
uridine 5'→3'-adenine dinucleotide;UpA;[3']Adenylsaeure-uridin-5'-ylester;Uridylyl(5'.2')adenosine;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯化学式
CAS
3051-84-1
化学式
C19H24N7O12P
mdl
——
分子量
573.413
InChiKey
RNNPIPQLZRGXIG-KPKSGTNCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.4
  • 重原子数:
    39
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    274
  • 氢给体数:
    7
  • 氢受体数:
    16

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Some observations relating to the use of 1-aryl-4-alkoxypiperidin-4-yl groups for the protection of the 2′-hydroxy functions in the chemical synthesis of oligoribonucleotides
    作者:Wayne Lloyd、Colin B. Reese、Quanlai Song、Anthony M. Vandersteen、Cristina Visintin、Pei-Zhou Zhang
    DOI:10.1039/a908149f
    日期:——
    The comparative rates of acid-catalysed removal of ten 1-aryl-4-methoxypiperidin-4-yl 8 (R = Me) [including the previously reported Ctmp 5 and Fpmp 6] protecting groups for the 2′-hydroxy functions in oligoribonucleotide synthesis are discussed. These studies have led to the development of the 1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl (Cpep) protecting group 8 (R = Et, R1 = R2 = H, R3 = Cl) which is both more stable than the Ctmp and Fpmp groups at pH 0.5 and more labile at pH 3.75. The influence of the ribonucleoside aglycone on the stability of the 2′-O-Fpmp and 2′-O-Ctmp protecting groups both at low and high pH is examined.
    讨论了在寡核苷酸合成中,十个1-芳基-4-甲氧基哌啶-4-基(R = Me,包括先前报道的Ctmp 5和Fpmp 6)保护基对2'-羟基功能的酸催化去除的相对速率。这些研究导致开发了1-(4-氯苯基)-4-乙氧基哌啶-4-基(Cpep)保护基8(R = Et,R1 = R2 = H,R3 = Cl),其在pH 0.5下比Ctmp和Fpmp群更加稳定,而在pH 3.75下更加不稳定。研究了核苷酸基在低pH和高pH下对2'-O-Fpmp和2'-O-Ctmp保护基稳定性的影响。
  • Simultaneous Interaction with Base and Phosphate Moieties Modulates the Phosphodiester Cleavage of Dinucleoside 3‘,5‘-Monophosphates by Dinuclear Zn<sup>2+</sup> Complexes of Di(azacrown) Ligands
    作者:Qi Wang、Harri Lönnberg
    DOI:10.1021/ja058806s
    日期:2006.8.1
    ability of the Zn(2+) complexes of these ligands to promote the transesterification of dinucleoside 3',5'-monophosphates to a 2',3'-cyclic phosphate derived from the 3'-linked nucleoside by release of the 5'-linked nucleoside has been studied over a narrow pH range, from pH 5.8 to 7.2, at 90 degrees C. The dinuclear complexes show marked base moiety selectivity. Among the four dinucleotide 3',5'-phosphates
    已经合成了五个双核配体 (1-5) 和一个三核配体 (6),其中包含连接到芳族支架上的 1,5,9-triazacyclododecan-3-yloxy 基团。这些配体的 Zn(2+) 复合物促进双核苷 3',5'-单磷酸酯转酯化为 2',3'-环状磷酸酯的能力,该磷酸酯衍生自 3'-连接的核苷,释放 5'已在 90 摄氏度的狭窄 pH 范围(从 pH 5.8 到 7.2)研究了-连接的核苷。双核复合物显示出显着的碱基部分选择性。在研究的四种二核苷酸 3',5'-磷酸中,即。adenylyl-3',5'-adenosine (ApA), adenylyl-3',5'-uridine (ApU), uridylyl-3',5'-adenosine (UpA), and uridylyl-3',5'-uridine (上U), 含有一个尿嘧啶碱基 (ApU 和 UpA) 的二聚体比含有两个尿嘧啶碱基
  • Dinuclear Zn<sup>2+</sup>complexes in the hydrolysis of the phosphodiester linkage in a diribonucleoside monophosphate diester
    作者:Morio Yashiro、Hideki Kaneiwa、Kenichi Onaka、Makoto Komiyama
    DOI:10.1039/b312301d
    日期:——
    Dizinc complexes that were formed from 2 ∶ 1 mixtures of Zn(NO3)2 and dinucleating ligands TPHP (1), TPmX (2) or TPpX (3) in aqueous solutions efficiently hydrolyzed diribonucleoside monophosphate diesters (NpN) under mild conditions. The dinucleating ligand affected the structure of the aquo-hydroxo-dizinc core, resulting in different characteristics in the catalytic activities towards NpN cleavage. The pH-rate profile of ApA cleavage in the presence of (Zn2+)2-1 was sigmoidal, whereas those of (Zn2+)2-2 and (Zn2+)2-3 were bell-shaped. The pH titration study indicated that (Zn2+)2-1 dissociates only one aquo proton (up to pH 12), whereas (Zn2+)2-2 dissociates three aquo protons (up to pH 10.7). The observed differences in the pH-rate profile are attributable to the various distributions of the monohydroxo-dizinc species, which are responsible for NpN cleavage. As compared to that using (Zn2+)2-1, the NpN cleavage using (Zn2+)2-2 showed a greater rate constant, with a higher product ratio of 3′-NMP/2′-NMP. The saturation behaviors of the rate, with regard to the concentration of NpN, were analyzed by Michaelis–Menten type kinetics. Although the binding of (Zn2+)2-2 to ApA was weaker than that of (Zn2+)2-1, (Zn2+)2-2 showed a greater kcat value than (Zn2+)2-1, resulting in higher ApA cleavage activity of the former.
    由2:1的Zn(NO3)2与双配体TPHP(1)、TPmX(2)或TPpX(3)在水溶液中形成的二锌复合物在温和条件下有效水解二核苷酸单磷酸二酯(NpN)。双配体的结构影响了水合羟基二锌核心的构造,导致其催化NpN裂解的活性特征有所不同。在(Zn2+)2-1存在下,ApA裂解的pH-速率曲线呈S型,而(Zn2+)2-2和(Zn2+)2-3的曲线则呈钟形。pH滴定研究表明,(Zn2+)2-1仅在pH达到12时解离一个水合质子,而(Zn2+)2-2在pH达到10.7时则解离三个水合质子。观察到的pH-速率曲线差异可归因于单羟基二锌物种的不同分布,这些物种是NpN裂解的关键。与使用(Zn2+)2-1相比,使用(Zn2+)2-2时的NpN裂解表现出更大的速率常数,且3′-NMP/2′-NMP的产物比例更高。关于NpN浓度的速率饱和行为通过米氏动力学分析。尽管(Zn2+)2-2对ApA的结合强度弱于(Zn2+)2-1,但(Zn2+)2-2的kcat值高于(Zn2+)2-1,导致前者在ApA裂解中的活性更强。
  • Synthesis of 1′#,2′,3′,4′#,5′,5″-2H6-β-D-ribonucleosides and 1′#, 2′,2″,3′,4′#,5′,5″-2H7-β-D-2′-deoxyribonucleosides for selective suppression of proton resonances in partially-deuterated oligo-DNA, oligo-RNA and in 2,5A core (1H-NMR window)
    作者:András Földesi、Frans Peder R. Nilson、Corine Glemarec、Carlo Gioeli、Jyoti Chattopadhyaya
    DOI:10.1016/s0040-4020(01)82001-9
    日期:1992.1
    1′#,2′,3′,4′#,5′,5″-2H6-ribonucleosides 13 16 were converted in high yields to the corresponding 1′#,2′,2″,3′,4′#,5′,5″-2H7-2′-deoxynucleosides 41 44 in the following manner: 3′,5′-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl (TPDS))-1′#,2′,3′,4#′,5′,5″-2H6-nucleosides 29 32 were converted to the corresponding 2′-O-phenoxythiocarbonyl derivatives 33 36, which were deoxygenated by tri-n-butyltin
    阮内镍-2 H 2 O在甲基α/β-D-呋喃核糖苷[α/β= 〜3:10] 1的差向异构体混合物上的交换反应产生了甲基1 #,2,3,4 #,5,5'- 2 H 6 -α/β-呋喃核糖苷2 [在C2,C3,C5 / 5'处为97原子%2 H;C 4(C4 #)〜85原子%2 H ;在C1(C1 #)]处约20个原子%2 H,以60 – 80%的产率获得,同时还得到了差向异构的木糖和阿拉伯糖副产物。在干燥的吡啶中将粗产物2甲苯磺酸化,并在硅胶柱上小心分离,得到纯的1-O-甲基-2,3,5-三-O-(4-甲苯甲酰基)-α/β-D-1#,2,3,4 #,5,5'- 2 H 6-核呋喃糖苷4(48%)。4转化为1-O-乙酰基-2,3,5-三-O-甲苯甲酰基-α/β-D-1 #,2,3,4 #,5,5'- 2 H 6-核呋喃糖苷6( 82%的人提供了合成氘核糖核苷用于RNA或DNA合成的关键组成部分。然后将化合物6与甲硅烷基尿嘧啶,N
  • Chemical synthesis of RNA via 2′-O-cyanoethylated intermediates
    作者:Hisao Saneyoshi、Kaori Ando、Kohji Seio、Mitsuo Sekine
    DOI:10.1016/j.tet.2007.07.102
    日期:2007.11
    could be removed from 2′-O-cyanoethylated ribonucleoside derivatives by treatment with Bu4NF. This finding was successfully applied to the synthesis of oligoribonucleotides via their 2′-O-cyanoethylated derivatives as key intermediates where a cyanoethyl group was used as the 2′-hydroxyl protecting group. The rate of condensation using this protecting group in the presence of various activators was generally
    发现通过用Bu 4 NF处理可以从2'- O-氰基乙基化的核糖核苷衍生物中除去2'- O-氰基乙基。该发现通过其2'- O-氰基乙基化衍生物作为关键中间体成功地应用于寡核糖核苷酸的合成,其中氰基乙基被用作2'-羟基保护基。在各种活化剂存在下,使用该保护基的缩合速率通常比将TBDMS基团用作保护基时观察到的速率要快。
查看更多

同类化合物

鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮 5'-dCT 2'-deoxyadenylyl-(3',5')-thymidine ammonium salt d(GpT) [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-prop-2-ynoxyoxolan-2-yl]methyl hydrogen phosphate pA3'p5'U pG3'p5'U pG3'p5'C cytidylyl-(3'-5')-3'-amino-3'-deoxy-3'-L-phenylalanyl-N6,N6-dimethyladenosine adenylyl-(3',5')-guanosine deoxyadenosyl(5'-3')thymidine phosphate cAIMP N4-palmitoyl-2'-deoxycytidylyl-(3'->5')-5-fluoro-2'-deoxyuridine